RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation
Amyloid-β protein (Aβ) is the main component of neuritic plaques, the pathological hallmark of Alzheimer’s disease (AD). β-site APP cleaving enzyme 1 (BACE1) is a major β-secretase contributing to Aβ generation. β-site APP cleaving enzyme 2 (BACE2), the homolog of BACE1, is not only a θ-secretase bu...
Main Authors: | Kaixin Qiu, Shuai Wang, Xin Wang, Fengting Wang, Yili Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2020/1920789 |
Similar Items
-
BACE2 degradation is mediated by both the proteasome and lysosome pathways
by: Kaixin Qiu, et al.
Published: (2020-03-01) -
Zwei neuartige Aspartylproteasen BACE-1 und BACE-2
by: Fluhrer, Regina
Published: (2003) -
Sorting nexin 12 interacts with BACE1 and regulates BACE1-mediated APP processing
by: Zhao Yonghao, et al.
Published: (2012-06-01) -
A Tale of Two Drug Targets: The Evolutionary History of BACE1 and BACE2
by: Christopher eSouthan, et al.
Published: (2013-12-01) -
Identification of BACE2 as an avid ß-amyloid-degrading protease
by: Abdul-Hay Samer O, et al.
Published: (2012-09-01)